100th Provider Joins MarginProbe® Program to Improve Breast Cancer Surgery

[vc_row][vc_column][vc_column_text] Emerging medical device company experiencing rapid growth Paoli, PA, Dec. 21, 2015– Dilon Devices announced today 100 breast centers have selected MarginProbe to help improve surgical outcomes for lumpectomy patients, marking a significant corporate milestone for the emerging medical device company. To date, there have been over 7,000 MarginProbe lumpectomies performed in 27 states…

Read More